Left ventricular noncompaction cardiomyopathy and short QT syndrome due to primary carnitine deficiency.
Oliver P HaningtonCatherine ArmstrongGermaine PierreGraham StuartJules C HancoxPublished in: Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc (2023)
We report the case of a 13-year-old female patient presenting with presyncope and palpitations. Her electrocardiogram revealed an abbreviation of the rate-corrected QT interval with imaging showing significant left ventricular dysfunction. Carnitine levels were measured as part of her diagnostic workup, discovering a rare, reversible cause of short QT syndrome (SQTS) and associated cardiomyopathy-primary carnitine deficiency (PCD) caused by a homozygous mutation in the SLC22A5 gene, leading to an in-frame deletion mutation (NP_003051.1:p.Phe23del) affecting the organic cation transporter 2 (OCTN2) protein. Following the treatment with oral carnitine supplementation, her QT interval returned to within the normal range with significant improvement in left ventricular function.
Keyphrases
- left ventricular
- heart failure
- case report
- drug induced
- hypertrophic cardiomyopathy
- cardiac resynchronization therapy
- acute myocardial infarction
- aortic stenosis
- mitral valve
- left atrial
- replacement therapy
- high resolution
- oxidative stress
- genome wide
- gene expression
- single cell
- copy number
- percutaneous coronary intervention
- coronary artery disease
- protein protein
- water soluble